Skip to main content
OpenTrials

Clinical trial condition

Urea Cycle Disorders, Inborn

Explore clinical trials studying Urea Cycle Disorders, Inborn. Study availability and eligibility vary by location and protocol.

49 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Urea Cycle Disorders, Inborn trial results

Completed

To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)

NCT01257737

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • UCLA Pediatrics/Genetics Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • Denver Children's Hospital Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 16 locations
View Trial Details
Completed

Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders

NCT00947544

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • UCLA Los Angeles, California, United States
  • The George Washington DC Children's National Medical Center Washington D.C., District of Columbia, United States
  • Mount Sinai School of Medicine New York, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)

NCT01347073

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • UCLA Pediatrics/Genetics Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Maine Medical Center Portland, Maine, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)

NCT00947297

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • Long Beach Memorial Long Beach, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders

NCT00992459

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • Long Beach Memorial Long Beach, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • Denver Children's Hospital Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs)

NCT03335488

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +10 more
Locations
  • University of Florida (UF) - Shands Hospital Gainesville, Florida, United States
  • Mount Sinai School of Medicine New York, United States
  • University Hospitals Case Medical Center Cleveland, Ohio, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions